Seeking Alpha

CORT
  Corcept Therapeutics Incorporated - NASDAQ

9/22/2014, 6:22 PM ET
  • anonymous#12 | Send Message 27 Aug 2012

    CORT, korlym sales seemed pretty weak taking in consideration it is a orphan drug indication. Neutral.
    Reply
      CORT vs. ETF Alternatives
      Company Description
      Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States